Business Description
Mingchen Health Co Ltd
ISIN : CNE1000033B9
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 8.9 | |||||
Equity-to-Asset | 0.73 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | 0.91 | |||||
Interest Coverage | 31.15 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 10.1 | |||||
Beneish M-Score | -3.06 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 34.3 | |||||
3-Year EBITDA Growth Rate | 25.8 | |||||
3-Year EPS without NRI Growth Rate | -11 | |||||
3-Year FCF Growth Rate | -28.6 | |||||
3-Year Book Growth Rate | 7.3 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 52.1 | |||||
9-Day RSI | 53.05 | |||||
14-Day RSI | 54.33 | |||||
6-1 Month Momentum % | 29.53 | |||||
12-1 Month Momentum % | -27.21 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.61 | |||||
Quick Ratio | 1.95 | |||||
Cash Ratio | 0.53 | |||||
Days Inventory | 137.24 | |||||
Days Sales Outstanding | 94.64 | |||||
Days Payable | 106.86 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.89 | |||||
Dividend Payout Ratio | 0.93 | |||||
Forward Dividend Yield % | 0.89 | |||||
5-Year Yield-on-Cost % | 0.91 | |||||
Shareholder Yield % | 1.9 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 57.31 | |||||
Operating Margin % | 5.51 | |||||
Net Margin % | 0.1 | |||||
FCF Margin % | 9.65 | |||||
ROE % | 0.15 | |||||
ROA % | 0.1 | |||||
ROIC % | 0.55 | |||||
ROC (Joel Greenblatt) % | 5.14 | |||||
ROCE % | 2.42 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 2395.71 | |||||
Forward PE Ratio | 4.89 | |||||
PE Ratio without NRI | 103.52 | |||||
Shiller PE Ratio | 67.08 | |||||
PEG Ratio | 2.75 | |||||
PS Ratio | 3.52 | |||||
PB Ratio | 5.11 | |||||
Price-to-Tangible-Book | 7.02 | |||||
Price-to-Free-Cash-Flow | 35.22 | |||||
Price-to-Operating-Cash-Flow | 32.08 | |||||
EV-to-EBIT | 205.07 | |||||
EV-to-EBITDA | 205.07 | |||||
EV-to-Revenue | 3.3 | |||||
EV-to-FCF | 33.11 | |||||
Price-to-Projected-FCF | 3.18 | |||||
Price-to-Graham-Number | 5.68 | |||||
Price-to-Net-Current-Asset-Value | 8.69 | |||||
Earnings Yield (Greenblatt) % | 0.49 | |||||
FCF Yield % | 2.85 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Mingchen Health Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 1,319.033 | ||
EPS (TTM) (Â¥) | 0.007 | ||
Beta | 0.94 | ||
Volatility % | 45.11 | ||
14-Day RSI | 54.33 | ||
14-Day ATR (Â¥) | 1.037692 | ||
20-Day SMA (Â¥) | 16.47 | ||
12-1 Month Momentum % | -27.21 | ||
52-Week Range (Â¥) | 10.17 - 22.616666 | ||
Shares Outstanding (Mil) | 266.53 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Mingchen Health Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Mingchen Health Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Mingchen Health Co Ltd Frequently Asked Questions
What is Mingchen Health Co Ltd(SZSE:002919)'s stock price today?
When is next earnings date of Mingchen Health Co Ltd(SZSE:002919)?
Does Mingchen Health Co Ltd(SZSE:002919) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |